[Brussels, 20th June 2025] – According to Clearview Market Insights (CVMI), the clinical trials market in Europe is projected to expand from USD 16.5 billion in 2024 to USD 25.8 billion by 2031, driven by regulatory reform, digital transformation, and a focus on rare diseases.
"Europe is becoming a globally attractive hub for multicountry trials and digital-first trial designs," said...